ClinicalTrials.gg
CompletedNCT07937761Updated Nov 16, 2026

Effects of Painting-Based Art Interventions in Individuals With Schizophrenia

An interventional study of Painting-Based Art Intervention in Schizophrenia, sponsored by Selcuk University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Selcuk University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jun 2026, registered Nov 2026).
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 95 studies in Schizophrenia with a site in Turkey — 19 open to participants now, 20 under way, none of them phase 3. Schizophrenia · Turkey.

Enrollment
36th of 80
60 · median 60
Started
2026
with 8 others
No phase
56 of 95
16 open now
Registered
95th of 95
by date

Among the 95 studies in Schizophrenia with a site in Turkey, this one is the 36th largest by enrollment of the 80 interventional ones that give a count, is one of 9 that started in 2026, is one of 56 with no phase, and was the 95th registered.

Schizophrenia

3,571 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.

Browse Schizophrenia studies →

Open to participants now

19 of the 95 studies in Schizophrenia with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Schizophrenia with a site in Turkey, or all of them as a file.
02

Study summary

This study was conducted to examine the effects of a painting-based art intervention on social isolation, psychological recovery, and happiness levels in individuals diagnosed with schizophrenia, as well as to investigate the indirect effects of changes in social isolation and psychological recovery on the relationship between the intervention and changes in happiness.

The study employed a randomized controlled, parallel-group, pre-test/post-test design. A total of 60 individuals diagnosed with schizophrenia were randomly assigned to an experimental group (n=30) or a control group (n=30). The experimental group received a structured painting-based art intervention consisting of eight one-hour sessions over approximately two months. The control group did not receive the painting-based art intervention.

Data were collected before and after the intervention period using a personal information form, the Hikikomori Social Isolation Scale, the Mental Health Recovery Scale, and the Oxford Happiness Questionnaire-Short Form. Mixed-design analysis of variance was used to evaluate group-by-time interactions, and bootstrap analyses were conducted to examine indirect effects.

Read the detailed description

This randomized controlled study was conducted at a Community Mental Health Center in Türkiye to evaluate the effects of painting-based art interventions on social isolation, psychological recovery, and happiness among individuals diagnosed with schizophrenia.

Participants were individuals aged 18-65 years with a diagnosis of schizophrenia who were registered at the center, met the eligibility criteria, and provided informed consent. Eligibility was assessed before randomization, and participants were allocated to either the experimental group or the control group using simple randomization. A total of 60 participants were randomized, with 30 individuals assigned to each group.

The experimental group received a structured painting-based art intervention delivered in a group setting over approximately two months. The intervention consisted of eight sessions, each lasting one hour. Activities included drawing, painting, visual expression, storytelling, and group discussions designed to encourage self-expression and social interaction.

The control group did not receive the structured painting-based art intervention during the study period.

Data were collected at baseline and after the intervention period using a personal information form, the Hikikomori Social Isolation Scale, the Mental Health Recovery Scale, and the Oxford Happiness Questionnaire-Short Form.

Mixed-design analysis of variance was used to examine group-by-time interactions. Bootstrap-based indirect effect analyses were conducted to investigate the roles of changes in social isolation and psychological recovery in the relationship between intervention assignment and changes in happiness.

The study was approved by the Selcuk University Faculty of Nursing Scientific Research Ethics Committee before participant recruitment and data collection.

03

Conditions studied

  • Schizophrenia

Keywords

  • schizophrenia
  • social Isolation
  • Psychologcial Recovery
  • Happiness
  • Painting-Based Art Intervention
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:Being between 18 and 65 years of age.

Having a diagnosis of schizophrenia.

Being registered at the Community Mental Health Center.

Having a Positive and Negative Syndrome Scale (PANSS) total score of 75 or below.

Being considered eligible to participate in the study by the treating psychiatrist.

Providing to participate in the study.

-

Exclusion Criteria:Not meeting the inclusion criteria.

Declining to provide informed consent.

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Painting-Based Art Intervention Group

    Participants assigned to the experimental group received a structured painting-based art intervention consisting of eight sessions, each lasting one hour, over approximately two months, in addition to usual care. Social isolation, psychological recovery, and happiness levels were assessed before and after the intervention.

    Behavioral: Painting-Based Art Intervention

  • No intervention
    Control Group

    Participants assigned to the control group did not receive the painting-based art intervention and continued to receive usual care. Social isolation, psychological recovery, and happiness levels were assessed at baseline and after approximately two months using the same measurement instruments as the experimental group.

Interventions

  • BehavioralPainting-Based Art Intervention

    The painting-based art intervention was conducted over approximately two months and consisted of eight structured group sessions, each lasting one hour. The sessions included drawing, painting, visual expression, and group activities aimed at promoting self-expression, social interaction, and psychological recovery among individuals diagnosed with schizophrenia.

06

What researchers measure

Primary outcomes

  1. Change in Social Isolation Level

    Social isolation was assessed using the 25-item Hikikomori Social Isolation Scale (HSI-25). Changes in social isolation scores from baseline to post-intervention were evaluated.

    Time frame: Baseline and post-intervention ( approximately 2 months)

  2. Psychological Recovery

    Psychological recovery was assessed using the 10-item Mental Health Recovery Scale. Scores were measured before and after the intervention.

    Time frame: Baseline and post-intervention (approximately 2 months)

  3. Change in Happiness Level

    Happiness was assessed using the Oxford Happiness Questionnaire-Short Form. Changes in happiness scores from baseline to post-intervention were evaluated.

    Time frame: Baseline and post-intervention (approximately 2 months)

07

Study locations

1 site
  • Selcuk University Faculty of Medicine, Department of Psychiatry, Community Mental Health Center Kopyala
    Konya, Selcuklu 004200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Jul 2026, 1 month.

Of 760 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's 1 month is below that.

Counting every sponsor, half of 773 studies reached it within 32 months; a quarter within 16 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartActual
Jun 1, 2026
Primary completionActual
Jul 30, 2026
CompletionActual
Jul 30, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937761
Lead sponsor
Selcuk University
Responsible party
Neslihan Lok (Professor, Selcuk University) — Principal investigator
First posted
Nov 16, 2026
Start date
Jun 1, 2026
Primary completion
Jul 30, 2026
Completion
Jul 30, 2026
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion